Search Results - "Chellappan, Dinesh K."

Refine Results
  1. 1

    Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems by Hardwick, Joel, Taylor, Jack, Mehta, Meenu, Satija, Saurabh, Paudel, Keshav R, Hansbro, Philip M, Chellappan, Dinesh K, Bebawy, Mary, Dua, Kamal

    Published in Current pharmaceutical design (2021)
    “…Curcumin is a major curcuminoid present in turmeric. The compound is attributed to various therapeutic properties, which include anti-oxidant,…”
    Get more information
    Journal Article
  2. 2

    Adenosine Receptors in Modulation of Central Nervous System Disorders by Choudhury, Hira, Chellappan, Dinesh K, Sengupta, Pallav, Pandey, Manisha, Gorain, Bapi

    Published in Current pharmaceutical design (01-01-2019)
    “…The ubiquitous signaling nucleoside molecule, adenosine is found in different cells of the human body to provide its numerous pharmacological role. The…”
    Get more information
    Journal Article
  3. 3

    Recent Trends in Rationally Designed Molecules as Kinase Inhibitors by Prasher, Parteek, Sharma, Mousmee, Chan, Yinghan, Singh, Sachin Kumar, Anand, Krishnan, Dureja, Harish, Jha, Niraj Kumar, Gupta, Gaurav, Zacconi, Flavia, Chellappan, Dinesh K, Dua, Kamal

    Published in Current medicinal chemistry (01-01-2023)
    “…Protein kinases modulate the structure and function of proteins by adding phosphate groups to threonine, tyrosine, and serine residues. The phosphorylation…”
    Get more information
    Journal Article
  4. 4

    Managing Apoptosis in Lung Diseases using Nano-assisted Drug Delivery System by Shukla, Monu K, Dubey, Amit, Pandey, Sadanand, Singh, Sachin K, Gupta, Gaurav, Prasher, Parteek, Chellappan, Dinesh K, Oliver, Brian G, Kumar, Deepak, Dua, Kamal

    Published in Current pharmaceutical design (01-01-2022)
    “…Several factors exist that limit the efficacy of lung cancer treatment. These may be tumor-specific delivery of therapeutics, airway geometry, humidity,…”
    Get more information
    Journal Article
  5. 5

    Pharmaceutical Aspects of Green Synthesized Silver Nanoparticles: A Boon to Cancer Treatment by Mishra, Vijay, Nayak, Pallavi, Singh, Manvendra, Tambuwala, Murtaza M, Aljabali, Alaa A, Chellappan, Dinesh K, Dua, Kamal

    Published in Anti-cancer agents in medicinal chemistry (01-01-2021)
    “…Silver nanoparticles (AgNPs) are among the most investigated nanostructures in recent years, which exhibit more challenging and promising qualities in…”
    Get more information
    Journal Article
  6. 6

    Metal‐based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy by Kumar, Sunil, Shukla, Monu Kumar, Sharma, Abhishek Kumar, Jayaprakash, Gururaj K., Tonk, Rajiv K., Chellappan, Dinesh K., Singh, Sachin Kumar, Dua, Kamal, Ahmed, Faheem, Bhattacharyya, Sanjib, Kumar, Deepak

    Published in MedComm (2020) (01-04-2023)
    “…Cancer is a disease associated with complex pathology and one of the most prevalent and leading reasons for mortality in the world. Current chemotherapy has…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    An Appraisal of the Current Scenario in Vaccine Research for COVID-19 by Chong, Wai Chin, Chellappan, Dinesh K, Shukla, Shakti D, Peterson, Gregory M, Patel, Rahul P, Jha, Niraj Kumar, Eri, Rajaraman D, Dua, Kamal, Tambuwala, Murtaza M, Shastri, Madhur D

    Published in Viruses (18-07-2021)
    “…The recent coronavirus disease 2019 (COVID-19) outbreak has drawn global attention, affecting millions, disrupting economies and healthcare modalities. With…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review by K, Akash, Sharma, Avinash, Kumar, Deepak, Singh, Sachin K., Gupta, Gaurav, Chellappan, Dinesh K., Dua, Kamal, Nagraik, Rupak

    Published in Journal of medical virology (01-10-2022)
    “…The global pandemic of COVID‐19 began in December 2019 and is still continuing. The past 2 years have seen the emergence of several variants that were more…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis by Bakshi, Hamid A., Mishra, Vijay, Satija, Saurabh, Mehta, Meenu, Hakkim, Faruk L., Kesharwani, Prashant, Dua, Kamal, Chellappan, Dinesh K., Charbe, Nitin B., Shrivastava, Garima, Rajeshkumar, S., Aljabali, Alaa A., Al-Trad, Bahaa, Pabreja, Kavita, Tambuwala, Murtaza M.

    Published in Inflammation (01-12-2019)
    “…Hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) inhibitors are shown to be protective in several models of inflammatory bowel disease (IBD). However,…”
    Get full text
    Journal Article
  15. 15

    Potentialities of aptasensors in cancer diagnosis by Sharma, Avinash, Dulta, Kanika, Nagraik, Rupak, Dua, Kamal, Singh, Sachin K., Chellappan, Dinesh K., Kumar, Deepak, Shin, Dong-Soo

    Published in Materials letters (01-02-2022)
    “…•Cancer is a life-threatening disease that affects people all over the world.•Biosensor a beneficial tool for the early identification and detection of a…”
    Get full text
    Journal Article
  16. 16

    Tumor suppressor role of miR-503 by Gupta, Gaurav, Chellappan, Dinesh K, de Jesus Andreoli Pinto, Terezinha, Hansbro, Philip M, Bebawy, Mary, Dua, Kamal

    Published in Panminerva medica (01-03-2018)
    “…MicroRNAs (miRNAs) are non-coding RNAs of around 20-25 nucleotides in length with highly conserved characteristics. They moderate post-transcriptional…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Nanocarriers: more than tour de force for thymoquinone by Rathore, Charul, Rathbone, Michael J, Chellappan, Dinesh K, Tambuwala, Murtaza M, Pinto, Terezinha De Jesus A, Dureja, Harish, Hemrajani, Chetna, Gupta, Gaurav, Dua, Kamal, Negi, Poonam

    Published in Expert opinion on drug delivery (02-04-2020)
    “…: Thymoquinone (TQ), 2-isopropyl-5-methylbenzo-1, 4-quinone, the main active constituent of Nigella sativa (NS) plant, has been proven to be of great…”
    Get more information
    Journal Article
  20. 20

    Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases by Shastri, Madhur D., Allam, Venkata Sita Rama Raju, Shukla, Shakti D., Jha, Niraj Kumar, Paudel, Keshav Raj, Peterson, Gregory M., Patel, Rahul P., Hansbro, Philip M., Chellappan, Dinesh K., Dua, Kamal

    Published in Life sciences (1973) (15-10-2021)
    “…Non-communicable, chronic respiratory diseases (CRDs) affect millions of individuals worldwide. The course of these CRDs (asthma, chronic obstructive pulmonary…”
    Get full text
    Journal Article